Fig. 3: Tumor growth inhibition assay in HeLa MCTS.
From: Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy
Change of the volume in MCTS in correlation to the time of the treatment. The MCTS were treated with compounds 1–7 (20 μM, 2% DMSO, v%), H2TPP (20 μM, 2% DMSO, v%), and cisplatin (10 μM and 30 μM). The MCTS were a strictly kept in the dark, b exposed to 1P irradiation (500 nm, 16.7 min, 10.0 mW cm−2, and 10 J cm−2), c exposed to 2P irradiation (800 nm, 10 J cm−2 with a section interval of 5 μm) on day 3. The error bars correspond to the standard deviation of the three replicates.
